Analysts’ Updated EPS Estimates for August, 24th (AP.UN, BNE, CIEN, CMG, CTRV, ESYJY, HAE, HRC, INO.UN, NWH.UN)
Allied Properties Real Estate Investment (TSE:AP.UN) had its market perform rating reiterated by analysts at BMO Capital Markets. They currently have a C$41.00 target price on the stock.
Bonterra Energy Corp (TSE:BNE) was upgraded by analysts at Raymond James Financial, Inc. from an outperform rating to a strong-buy rating. The firm currently has C$26.00 target price on the stock.
Ciena Corporation (NYSE:CIEN) had its outperform rating reissued by analysts at Raymond James Financial, Inc..
Chipotle Mexican Grill (NYSE:CMG) had its buy rating reissued by analysts at William Blair.
ContraVir Pharmaceuticals (NASDAQ:CTRV) was given a $4.00 target price by analysts at Maxim Group. The firm currently has a buy rating on the stock.
Easyjet Spon (OTCMKTS:ESYJY) was downgraded by analysts at BNP Paribas from a neutral rating to an underperform rating.
Haemonetics Corporation (NYSE:HAE) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $46.00 target price on the stock. According to Zacks, “Over the last month, Haemonetics has been trading above the broader industry. The company swung to operating income in the last reported first quarter from losses in the year-ago quarter. Also the year-over-year increase in reported sales and gross margin buoys optimism. Meanwhile, the company’s strong cash position boosts investors’ confidence. The company is also optimistic about strong market adoption of its NexSys PCS plasmapheresis system which recently received FDA approval. On the flip side, despite the encouraging growth in the Plasma and Haemonetics Management franchises, the underperformance at BloodCenter was quite a dampener in the last reported quarter. Moreover, currency headwinds and tough competitive landscape may continue to pose challenges for the company going forward.”
Hill-Rom Holdings (NYSE:HRC) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Over the last three months, Hill-Rom has been underperforming the broader industry. Moreover, it exited the last reported quarter on a mixed note with earnings ahead of estimates but revenues missing the same. Also, decrease in Patient Support Systems revenues was disappointing. Moreover, a decline in reported gross margin was dampening. Also, lowered full year guidance suggests dull prospects ahead. On a positive note, Hill-Rom saw a solid year-over-year increase in revenues on strong international growth. Hill-Rom currently aims to gain traction in the untapped international market on successful execution. The company is focusing on product innovation through research and development. Also, its launches slated for the fourth quarter are pumping up investors’ confidence. With regard to this, the commercial launch of its Centrella Med-Surg platform is worth a mention.”
Inovalis Real Estate Investment Trust (TSE:INO.UN) had its outperform rating reaffirmed by analysts at BMO Capital Markets. The firm currently has a C$11.35 price target on the stock.
NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) had its market perform rating reaffirmed by analysts at BMO Capital Markets. The firm currently has a C$12.00 price target on the stock.
Royal Bank of Canada (TSE:RY) (NYSE:RY) had its market perform rating reaffirmed by analysts at BMO Capital Markets. BMO Capital Markets currently has a C$100.00 target price on the stock.